Generate a tailored SOP for Dr. Anthony Reder. Improve your application with a focused, well-structured draft.
Dr. Anthony Reder is a professor at the University of Chicago, with over 30 years of dedicated research in multiple sclerosis (MS) and neuroimmunology. He has significantly contributed to the field through co-authoring approximately 150 papers and presenting extensively on MS and related topics. His primary research interests focus on the interaction between the central nervous system (CNS) and the cellular immune system, investigating how these relationships are altered in MS. Dr. Reder leads an active research lab that studies the immune disruption in MS, including the mechanisms of action of interferon-beta, a common treatment for MS. His work has revealed defects in the interferon signaling pathway in lymphocytes, which has implications for treating progressive forms of MS. He played a crucial role in developing various treatments for MS, including biological therapies and multiple drugs that have been transformative for patients. Dr. Reder's ongoing clinical trials explore promising new drugs for neuromyelitis optica and progressive MS. As a mentor, he has trained numerous fellows in MS, funded by the National MS Society, further extending his impact on the field.
University of Chicago • Chicago, IL
Professor of Neurology with a focus on multiple sclerosis and neuroimmunology.
Department of Philosophy